Gentaur reagents of Lab PCR Assays

February 3, 2024 0 Comments

Compare Assays lab reagents for research

February 2, 2024 0 Comments

Suppliers for Lab ELISAs Our used rec. in Pubmed.

Compare Appoptosis lab reagents for research

February 2, 2024 0 Comments

Suppliers for Lab reagents Our used polyclonals in Pubmed. https://tumori.net/

Compare ELISA lab reagents for research

December 29, 2022 0 Comments

Suppliers for Lab recombinants Our used rec. in Pubmed.

Compare ELISA lab reagents for research

December 29, 2022 0 Comments

Suppliers for Lab reagents Our used References in Pubmed.

monoclonal Lab Reagents for Research

December 28, 2022 0 Comments

Promoted Lab monoclonals Our used recombinants in Pubmed.

Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies

February 15, 2022 0 Comments

Ebola virus (EBOV) is an enveloped, single-stranded RNA virus that can cause Ebola virus disease (EVD). It is thought that EVD survivors are protected against subsequent infection with EBOV and that neutralising antibodies to the viral surface glycoprotein (GP) are potential correlates of protection. Serological studies are vital to assess neutralising antibodies targeted to EBOV …

Anti-CD25 monoclonal antibody enhances the protective efficacy of Schistosoma japonicum GST vaccine via inhibition of CD4+CD25+Foxp3+ regulatory T cells

February 15, 2022 0 Comments

The effect of anti-CD25 monoclonal antibody (anti-CD25 mAb) on the protection efficacy of Schistosoma japonicum 26 kDa GST (glutathione-S-transferase) vaccine was evaluated. Mice were immunized with GST before infection with S. japonicum cercariae and then injected with anti-CD25 mAb. The worm reduction rate was promoted from 24.18% in mice with GST immunization to 47.09% in …

Effect of COVID-19 on Anti-S Antibody Response in Healthcare Workers Six Months Post-Vaccination

February 15, 2022 0 Comments

The current study aimed to determine to what extent prior COVID-19 infection affects the response of specific antibodies following vaccination. The study involved 173 healthcare professionals who completed the two-dose vaccination course with BNT162b2, including 40 who previously experienced clinical COVID-19. The levels of anti-SARS-CoV-2 S1S2 IgG (anti-S) and, in some cases, anti-SARS-CoV-S-RBD IgG (anti-S-RBD) …